This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. we assessed the extent of cell injury using a WST-8 assay at 24 h after aspirin-stimulation. We performed the same procedure in MDR1 gene-transfected Caco2 cells. To determine the function of MDR1 in the metabolism of aspirin, flux study was performed using 14 C-labeled aspirin. Results: The level of aspirin-induced cell injury was higher in verapamil-treated Caco2 cells than in control cells and was less serious in MDR1-transfected Caco2 cells than in control vector-transfected cells. The efflux of 14 C-labeled aspirin was higher in verapamil-treated Caco2 cells than in control cells. Conclusion: These data suggest that aspirin efflux occurs through the MDR1 transporter and that the MDR1 transporter is involved in the pathogenesis of aspirin-induced cell injury.
MDR1 is Related to Intestinal Epithelial Injury Induced by Acetylsalicylic Acid

Introduction
The clinical use of aspirin has increased because of the general aging of the population and the increasing prevalence of atherosclerosis and diabetes, which are risk factors for ischemic cardiovascular disease [1] . The development of endoscopic diagnostic techniques, such as video capsule endoscopy and balloon enteroscopy, for small intestinal diseases has provided clear evidence that aspirin can induce intestinal mucosal injury in addition to gastric injury [2] . Although the pathophysiology of aspirin-induced intestinal epithelial cellular injuries has been extensively researched and clarified, practical therapies for such injuries are unavailable. Therefore, it is important to develop preventive and therapeutic strategies for aspirin-induced intestinal epithelial cellular injuries.
The Multi Drug Resistance (MDR) transporter encoded by the MDR1 gene belongs to the adenosine triphosphate (ATP)-binding cassette (ABC) superfamily of membrane transporters [3] . MDR1 was identified in a MDR strain of cancer [4] . However, MDR1 is also expressed in the brush border of the proximal tubule of the kidney and in the bile duct of liver cells, which play an important role in the excretion of endogenous substances, such as drugs and other substances [3] . Further, MDR1 is expressed at the apical (AP) surface tip of the mucosal epithelial cells in the small and large intestines [4] , where it acts to export unnecessary or toxic exogenous substances or metabolites and where it may play a role in limiting the enteral absorption of a number of structurally unrelated drugs.
A recent report evaluated whether the genotypes of uptake and efflux transporters, including MDR1, are related to peptic ulcer and/or ulcer bleeding associated with aspirin use [5] , but an association between MDR1 and aspirin-induced small intestinal epithelial cellular injury has not been reported. The present study investigated the role of MDR1 in aspirin-induced intestinal epithelial cellular injury using a pharmacological blocker of MDR1 in MDR1-overexpressing Caco2 intestinal epithelial cells.
Materials and Methods
Cell culture
The human colon carcinoma cell line, Caco2, was cultured in plastic dishes at 37°C in a humidified incubator with 5% CO 2 /95% air in Dulbecco's Modified Eagle's Medium (Invitrogen/GIBCO, Grand Island, NY) supplemented with 10% fetal bovine serum, penicillin (100 U/mL), and streptomycin (100 μg/mL). Caco2 was cultured for 2 weeks to differentiate as intestinal epithelial cell.
mRNA analysis
The mRNA levels of MDR1 were determined by real-time polymerase chain reaction (PCR) from samples. Total RNA was isolated from samples by the acid guanidinium phenol chloroform method, using an ISOGEN kit (Nippon Gene, Tokyo, Japan). The concentration of RNA was determined by the absorbance at 260 nm in relation to that at 280 nm. The isolated RNA was stored at -80°C until it was used for the real-time PCR assay. Extracted RNA (1 µg) was reverse-transcribed into first-strand cDNA at 42°C for 40 min, using 100 U/mL of reverse transcriptase (Takara Biomedicals, Shiga, Japan) and 0.1 μM of oligo (dT)-adapter primer (Takara Biomedicals) in a 50-μL reaction mixture. Real-time PCR for human MDR1 was carried out with a 7300 real-time PCR DNA-binding dye SYBR green I for the detection of PCR products. The reaction mixture (RT-PCR kit, Code RRO43A; Takara Biochemicals) contained 12.5 μL Premix Ex Taq, 2.5 μL SYBR green I, custom-synthesized primers, ROX reference dye, and cDNA (equivalent to 20 ng total RNA) in a final reaction volume of 25 μL. The PCR settings were as follows: initial denaturation for 15 s at 95°C was followed by 40 cycles of amplification for 3 s at 95°C and 31 s at 60°C, with subsequent melting curve analysis increasing the temperature from 60°C to 95°C. The primers had the following sequences: for MDR1, sense: 5'-GTC CCA GGA GCC CAT CCT-3', and antisense: 5'-CCC GGC TGT TGT CTC CAT A-3'; and for human β-actin, sense: 5'-TAT CCA CCT TCC AGC AGA TGT-3', and antisense: 5'-TAT CCA CCT TCC AGC AGA TGT-3'. Relative quantification of gene expression with real-time PCR data was calculated relative to β-actin.
Western blot analysis
For western blot analysis, samples were harvested and total proteins were mixed with sodium dodecyl sulfate (SDS) sample buffer. The samples were subjected to 7% SDS-polyacrylamide gel electrophoresis (PAGE) and blotted onto a polyvinylidene difluoride (PVDF) membrane (Atto Corporation, Tokyo, Japan). The membrane was blocked with 2% bovine serum albumin in TBS-T (Tris-buffered saline and 0.1% Tween 20) at room temperature for 30 min. Western blotting was carried out using anti-MDR1 (P-gp) antibody (C219; Calbiochem, Darmstadt, Germany) at room temperature for 1 h. After three washes with TBS-T, the membrane was incubated with anti-mouse IgG-HRP (NA934V; GE Healthcare UK, Ltd., Chalfont St. Giles, UK) at room temperature for 60 min. The signals were visualized using an enhanced chemiluminescence (ECL) kit (GE Healthcare UK, Ltd.) according to the manufacturer's instructions.
Cell viability assay
Cell viability was assessed by use of the WST-8 labeling kit (Roche Diagnostics, Mannheim, Germany) at 24 h after treatment with aspirin and verapamil (or no treatment for control). The medium was removed, and 100 μL of fresh medium with 10 μL WST-8 labeling solution was added. Measurements (OD (optical density) 450 nm) were taken after 1 h at 37°C via a microplate enzyme-linked immunosorbent assay (ELISA) reader.
Cell death assay
After exposure to an additional 20 mM aspirin for 24 h, the cells were stained in the culture medium with 0.15 mg/mL of Hoechst 342. In Hoechst 342 staining, chromatin agglutination cells were counted in 10 randomly selected fields of vision, and the ratio of chromatin agglutinated cells to normal cells was calculated.
Transfection of Caco2 cells with an MDR1 expression vector
Human cDNA was subcloned into pcDNA and transfected into Caco2 cells using the polyamine-derived reagent LT-1 (Mirus, Madison, WI). Clones were selected on the basis of G418 (600 µg/mL) resistance and were individually propagated for flux studies. The degree of MDR1 transfection of cells was assessed by measuring digoxin efflux by MDR1 protein western blotting and by determination of MDR1 mRNA levels by PCR.
Transport experiments
[Acetyl- 4 , 136.7 mM NaCl, 0.385 mM Na 2 HPO 4 , 25 mM D-glucose, and 10 mM HEPES, pH 7.4) for 30 min at 37°C. After pre-incubation, the transepithelial electrical resistance (TEER) was measured routinely with a Millicell-ERS system (Millipore Corporation, Bedford, MA) before experiments to ensure cell monolayer integrity. Caco2 cells that exhibited TEER values higher than 300 Ω/cm 2 were used for transport experiments. Transport measurement was initiated by adding aspirin (1 mM) to the donor side and transport medium to the receiver side. Transport of aspirin was measured in two directions, apical (AP) to basolateral (BL) and BL to AP. An aliquot of transport buffer was obtained from the donor side at 5 min for measurement of initial concentration and from the receiver side at 30, 60, 90, and 120 min. Transport experiments were performed under the same pH conditions (AP pH=7.4, BL pH=7.4). All experiments were performed in a 37°C room.
The apparent permeability coefficient (P app , cm/s) was calculated from the following equation:
where dQ/dt is the rate of permeation of aspirin across cell monolayers, C 0 is the initial concentration of aspirin in the donor compartment (µM), and A is the membrane surface area (0.9 cm 2 in the present study). An efflux ratio is calculated from the mean AP to BL (A-B) P app data and BL to AP (B-A) P app data from the following equation:
Flux study Caco2 cells were grown in 12-well plastic plates until differentiated, and then half of them were treated with 10 µM of verapamil-conditioned medium. The other half was treated with verapamil-free medium for
Results
MDR1 expression in MDR1
High cells Real-time PCR and western blotting was performed to characterize the expression of MDR1 in MDR1
High cells. Both mRNA and protein levels were higher in MDR1 High cells than in control cells (Fig. 1A, 1B) .
Cellular injury by aspirin, and protection by MDR1 overexpression
Aspirin treatment (20 mM) resulted in a decrease of cellular viability by 60% when compared with non-treated control cells (Fig. 2A) . Without aspirin treatment, the inhibition of MDR1 by verapamil and MDR1 overexpression (MDR1 high ) did not affect cellular viability (Fig. 2B, four bars from the left) . After aspirin treatment, verapamil potentiated the decrease in cellular viability in control cells. This decrease was reversed in MDR1 High cells, an action which, in turn, was prevented by verapamil (Fig. 2B, four bars from the right) .
Cell death assay
The proportion of cells with chromatin agglutination was higher in aspirin-treated control cells. Further, treatment with verapamil resulted in an increase in the proportion of cells with chromatin agglutination in both control and MDR1
High cells without verapamil treatment. Aspirin-induced chromatin agglutination was attenuated in MDR1
High cells (Fig.  2C, 2D ), and this attenuated response was blocked by verapamil (Fig. 2C) .
Transport experiments
When aspirin, including 14 C-aspirin, was added to the AP side of Transwell inserts, the verapamil-treated cells showed higher concentration of aspirin in the BL side at 120 min High Caco2 cells and control vectortransfected cells (**p<0.01). Both mRNA and protein levels were higher in MDR1
High cells than in control cells. Statistical significance was determined by ANOVA followed by Tukey's HSD test.
after aspirin treatment than verapamil-free cells (Fig. 3A) . The assay was also performed in the opposite direction. Even at 120 min, the AP concentration of aspirin was the same in both verapamil-treated and verapamil-free cells; at 30 min after aspirin treatment, AP concentrations of aspirin were significantly lower in verapamil-treated cells than in verapamil-free cells (Fig. 3B) . These data indicate that the permeability of aspirin was significantly changed in both directions in response to verapamil treatment. Verapamil treatment also significantly lowered the efflux ratio of aspirin (Table 1) . The permeability ratio was calculated as: (BL to AP / AP to BL). Data are represented as means±SEM (n=3). Statistical significance was determined by ANOVA followed by Tukey's HSD test. Verapamil treatment also significantly lowered the efflux ratio of aspirin.
Flux study
Fig. 4. Intracellular aspirin concentration of control vector-transfected cells and MDR1
High cells.
14 C-aspirin was measured after 10 min of aspirin treatment with and without verapamil. Each value indicates the mean±SE for five sets of experiments (**p<0.01). Statistical significance was determined by ANOVA followed by Tukey's HSD test. After 10 min of aspirin treatment, verapamil increased the concentration of aspirin in control cells. The concentration of aspirin was significantly lower in MDR1
High cells than in control cells. Verapamil treatment increased the concentration of aspirin in MD-R1
Discussion
Nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, inhibit the production of prostaglandins (PGs). In the gastrointestinal tract, PGs are very important mediators of mucosal defense and repair. Suppression of PG synthesis is the key effect of NSAIDs that leads to gastrointestinal mucosal injury [6] . The present study demonstrated that the cellular viability of Caco2 intestinal epithelial cells decreased in response to aspirin treatment in a concentration-dependent manner and that aspirin predominantly induced apoptosis in these cells. The increase in apoptotic cell death was significantly enhanced by co-treatment with verapamil, a blocker of MDR1, and was reversed in MDR1
High cells. The transport study and the flux study using 14 C-aspirin confirmed that aspirin is a substrate of MDR1 and that the intracellular concentration of aspirin was regulated by transmembrane passive diffusion as well as transport through MDR1. These results suggest that the induction or overexpression of MDR1 in the small intestine could suppress aspirin-induced small intestinal epithelial cellular injury.
Oral administration of aspirin does not cause small intestinal epithelial cellular injury directly, because aspirin is rapidly absorbed from the stomach and duodenum under acidic conditions and because of the lack of enterohepatic recirculation [7] . However, recent enteroscopic studies have clearly demonstrated that low-dose aspirin (usually entericcoated) induces hemorrhagic lesions, including ulcers and bleeding, in the small intestine in patients. Using capsule endoscopy, Endo et al. [8] demonstrated that enteric-coated aspirin might be more injurious to the small intestine than buffered aspirin. Nonoyama et al. [9] clearly showed that the injection of aspirin into the duodenum could induce intestinal hemorrhagic lesions in rats. These data suggest that aspirin must interact directly with the intestinal mucosa to produce injury. Although the concentration of aspirin in human plasma is extremely low because of hydrolysis [10] , the mucosal concentration of aspirin might be much higher, especially in patients treated with enteric-coated aspirin. Studies of the oral administration of aspirin in rats have shown that aspirin causes gastric injury in the stomach at concentrations between 10 and 100 mM [11] . In addition, aspirin could induce cell death in Caco2 cells at concentrations of 5 mM [12] . Therefore, the concentrations of aspirin used in this study (10 and 20 mM) might be physiologically relevant to those used in previous studies. The present study demonstrated the dose-dependent cytotoxic effects of aspirin on differentiated Caco2 cells, which have features of human epithelial cells of the small intestine, and confirmed that aspirin predominantly induced apoptosis in these cells according to biochemical and morphological analysis for cellular death. Further, this study demonstrated that the decrease in cell viability and the increase in apoptotic cells in Caco2 cells treated with aspirin were potentiated in cells co-treated with verapamil, a blocker of MDR1. By contrast, the decrease in cell viability did not occur in MDR1
High cells. Finally, this study confirmed that neither verapamil alone nor MDR1 transfection alone affected cell viability of Caco2 cells in the absence of aspirin. These results indicate that MDR1 plays a critical role in the pathogenesis of aspirin-induced apoptotic cell death of small intestinal epithelial cells.
Human MDR1 encodes a drug transporter p-glycoprotein with very broad substrate specificity. Various compounds with different structures and properties are transported by p-glycoprotein. This study utilized transport experiments and flux experiments using 14 C-aspirin to determine whether aspirin is a substrate of MDR1 in Caco2 intestinal epithelial cells. First,
14
C-aspirin was added to the AP side of the Transwell insert, and the concentration of aspirin was monitored in the BL side with and without verapamil. The BL concentration of aspirin was increased in a time-dependent manner after the administration of aspirin in the AP side. P app (1.31±0.15) was significantly increased by the presence of verapamil (1.47±0.09). Next, we performed the transport experiment in the opposite direction (adding These results clearly indicate that aspirin efflux occurs through the MDR1 transporter, because the efflux ratio was greater than 2.
Finally, we compared the intracellular aspirin concentrations between the control and MDR1
High Caco2 cells after treatment with aspirin. The present results showed that the concentration of aspirin in MDR1
High Caco2 cells was significantly decreased when compared with control cells and that the decrease in aspirin concentration was reversed by cotreatment with verapamil. These results also indicate that aspirin can enter into Caco2 cells with passive diffusion and is pumped out from the cells by the MDR1 transporter. Since this study also showed that MDR1 plays a critical role in the pathogenesis of aspirin-induced apoptotic cell death of Caco2 cells, it is possible that MDR1 affects aspirin-induced cell death via regulation of intracellular aspirin concentrations. In fact, data from the present study suggest that induction of MDR1 in intestinal epithelial cells could suppress aspirin-induced small intestinal injury. However, we should stress that high expression of MDR1 in intestinal epithelial cells is not always good, because it has been reported that there is a positive correlation between P app (AP to BL) and intestinal absorption of target drugs [13] . Aspirin can induce MDR1 expression in Caco2 cells [14] . Therefore, induction of MDR1 may be a self-defense system against intestinal epithelial cellular injury by decreasing cellular aspirin concentration. Further, disturbance of MDR-1 induction may be related to a high risk for aspirin-induced small intestinal injury. Sharma et al. [15] recently described the association between the C3435T MDR1 gene polymorphism and aspirin resistance. Further research regarding the relationship between MDR1 gene polymorphism and small intestinal injury in patients with prolonged use of aspirin would be of benefit.
In conclusion, the present study demonstrated that MDR1 plays a crucial role in the intestinal epithelial cell permeability of aspirin and in aspirin-induced apoptotic cell death. Further, MDR1 overexpression could prevent this type of cell death. Additional study to identify agents that can induce MDR1 expression in intestinal epithelial cells and prevent aspirin-induced intestinal injury would be of benefit.
